Hyperphosphatemia Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Novel Therapeutics and Rising CKD Burden | DelveInsight

TS-172Positive

AI Analysis

Summary

Market analysis report projects robust growth in the hyperphosphatemia market through 2036, driven by rising chronic kidney disease prevalence and novel therapies including Taisho's TS-172.

Importance:2/10

Sentiment:

0.50

market analysishyperphosphatemiachronic kidney diseasenovel therapeuticsforecast

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Biotech on August 5, 2026 2:31 PM

Read Original